Winters Jeffrey L
Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Semin Dial. 2012 Mar-Apr;25(2):145-51. doi: 10.1111/j.1525-139X.2011.01025.x. Epub 2012 Jan 25.
Low-density lipoprotein (LDL) apheresis describes a group of apheresis techniques that selectively remove apolipoprotein B-containing lipoproteins producing an acute reduction in LDL-cholesterol (LDL-C). Six devices are available for the removal of LDL-C while sparing other important plasma components. The LDL-apheresis (LDL-A) is not routinely used for the treatment of hypercholesterolemia, which usually responds to medical management, but is used to treat familial hypercholesterolemia, an inherited metabolic abnormality resulting in premature death due to progressive coronary artery disease, and to treat patients who fail medical management. The mechanism of action of the available LDL-A devices, reactions that can occur with these treatments, and the role of this specialized apheresis technique in the treatment of hypercholesterolemia are described.
低密度脂蛋白(LDL)单采术描述了一组单采技术,这些技术可选择性去除含载脂蛋白B的脂蛋白,使低密度脂蛋白胆固醇(LDL-C)急剧降低。有六种设备可用于去除LDL-C,同时保留其他重要的血浆成分。LDL单采术(LDL-A)通常不用于治疗高胆固醇血症,高胆固醇血症通常对药物治疗有反应,但用于治疗家族性高胆固醇血症,这是一种遗传性代谢异常,可因进行性冠状动脉疾病导致过早死亡,也用于治疗药物治疗无效的患者。本文描述了现有LDL-A设备的作用机制、这些治疗可能发生的反应,以及这种特殊单采技术在高胆固醇血症治疗中的作用。